The 340B program has grown dramatically, but many health plans still lack visibility into how it impacts reimbursement, rebates, and total drug costs. Learn why claim-level transparency is becoming essential.
Year-end testing is essential to validate claims accuracy, ensure compliance with IRA mandates, and confirm PDE reporting integrity. This process guarantees that your systems are prepared for the new contract…
The Inflation Reduction Act (IRA) is poised to bring a significant transformation to the Medicare Part D benefit starting in 2025. This redesign will impact many stakeholders, including Part D…